Advertisement

Neonatology pp 804-818 | Cite as

Physiology and Abnormalities of Leukocytes

  • Kurt R. Schibler

Abstract

The circulating pool of neutrophils reflect a dynamic equilibrium between neutrophil precursors and mature neutrophils in the bone marrow, circulating neutrophils and activated neutrophils that have migrated into the tissues. The bone marrow is the predominant hematopoietic organ after birth. Within the bone marrow, pluripotential hematopoietic stem and progenitor cells give rise to lineage committed neutrophil precursors. These precursors mature under the influence of growth factors such as granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF). The bone marrow thus contains pools of immature neutrophils and of stored mature neutrophils. After leaving the bone marrow, neutrophils are transiently in the circulation for a brief period of hours after which they translocate into the tissues.

Keywords

Hematopoietic Stem Cell Transplantation Chronic Granulomatous Disease Dyskeratosis Congenita Leukocyte Adhesion Deficiency Congenital Neutropenia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Luchtman-Jones L, Schwartz AL, Wilson DB (2002) Hematologic problems in the fetus and neonate. In: Fanaroff AA, Martin RJ (eds) Neonatal-perinatal medicine: Diseases of the fetus and infant, Vol 2, 7th edn. Mosby, St. Louis, pp 1205–1206Google Scholar
  2. 2.
    Maheshwari A, Christensen RD (2004) Developmental granulopoiesis. In: Polin RA, Fox WW Abman SH (eds) Fetal and neonatal physiology, Vol 2, 3rd edn. Saunders, Philadelphia, pp 1388– 1396Google Scholar
  3. 3.
    Manroe BL, Weinberg AG, Rosenfeld CR, Browne R (1979) The neonatal blood count in health and disease. I. Reference values for neutrophilic cells. J Pediatr 95: 89–98Google Scholar
  4. 4.
    Mouzinho A, Rosenfeld CR, Sanchez PJ, Risser R (1994) Revised reference ranges for circulating neutrophils in very-low-birthweight neonates. Pediatrics 94: 76–82PubMedGoogle Scholar
  5. 5.
    Douglas SD, Yoder MC (1996) The mononuclear phagocyte and dendritic cell systems. In: Stiehm ER (ed) Immunologic disorders in infants and children, 4 edn. WB Saunders, Philadelphia, pp 113–132Google Scholar
  6. 6.
    Trubowitz S, Davies S (1982) Pathophysiology of the monocytemacrophage system. In: Trubowitz S, Davies S (eds) The human bone marrow: Anatomy, physiology, and pathophysiology. CRC Press, Boca Raton FL, pp 95–126Google Scholar
  7. 7.
    Meuret G, Batara E, Furste HO (1975) Monocytopoiesis in normal man: Pool size, proliferation activity and DNA synthesis time of promonocytes. Acta Haematol 54: 261–270Google Scholar
  8. 8.
    van Furth R, Raeburn JA, van Zwet TL (1979) Characteristics of human mononuclear phagocytes. Blood 54: 485–500PubMedGoogle Scholar
  9. 9.
    Haller O, Arnheiter H, Lindenmann J (1979) Natural, genetically determined resistance toward influenza virus in hemopoietic mouse chimeras. Role of mononuclear phagocytes. J Exp Med 150: 117–126Google Scholar
  10. 10.
    Parwaresch MR, Wacker HH (1984) Origin and kinetics of resident tissue macrophages. Parabiosis studies with radiolabelled leucocytes. Cell Tissue Kinet 17: 25–39Google Scholar
  11. 11.
    Volkman A (1966) The origin and turnover of mononuclear cells in peritoneal exudates in rats. J Exp Med 124: 241–254PubMedCrossRefGoogle Scholar
  12. 12.
    Thomas ED, Ramberg RE, Sale GE et al (1976) Direct evidence for a bone marrow origin of the alveolar macrophage in man. Science 192: 1016–1018PubMedCrossRefGoogle Scholar
  13. 13.
    Gale RP, Sparkes RS, Golde DW (1978) Bone marrow origin of hepatic macrophages (kupffer cells) in humans. Science 201: 937–938PubMedCrossRefGoogle Scholar
  14. 14.
    van Furth R (1992) Development and distribution of mononuclear phagocytes. In: Gallin JI, Goldstein IM, Snyderman R (eds) Inflammation: Basic principles and clinical correlates. Raven Press, New York, pp 325–340Google Scholar
  15. 15.
    Pahwa SG, Pahwa R, Grimes E, Smithwick E (1977) Cellular and humoral components of monocyte and neutrophil chemotaxis in cord blood. Pediatr Res 11: 677–680PubMedCrossRefGoogle Scholar
  16. 16.
    Krause PJ, Herson VC, Boutin-Lebowitz J et al (1986) Polymorphonuclear leukocyte adherence and chemotaxis in stressed and healthy neonates. Pediatr Res 20: 296–300PubMedCrossRefGoogle Scholar
  17. 17.
    Carr R, Pumford D, Davies JM (1992) Neutrophil chemotaxis and adhesion in preterm babies. Arch Dis Child 67: 813–817PubMedCrossRefGoogle Scholar
  18. 18.
    Bokoch GM (1995) Chemoattractant signaling and leukocyte activation. Blood 86: 1649–1660PubMedGoogle Scholar
  19. 19.
    Sozzani S, Allavena P, Vecchi A, Mantovani A (1999) The role of chemokines in the regulation of dendritic cell trafficking. J Leukoc Biol 66: 1–9PubMedGoogle Scholar
  20. 20.
    Chan VW, Kothakota S, Rohan MC et al (1999) Secondary lymphoid- tissue chemokine (slc) is chemotactic for mature dendritic cells. Blood 93: 3610–3616PubMedGoogle Scholar
  21. 21.
    Marodi L, Csorba S, Nagy B (1980) Chemotactic and random movement of human newborn monocytes. Eur J Pediatr 135: 73–75PubMedCrossRefGoogle Scholar
  22. 22.
    Weston WL, Carson BS, Barkin RM et al (1977) Monocytemacrophage function in the newborn. Am J Dis Child 131: 1241–1242PubMedGoogle Scholar
  23. 23.
    Klein RB, Fischer TJ, Gard SE et al (1977) Decreased mononuclear and polymorphonuclear chemotaxis in human newborns, infants, and young children. Pediatrics 60: 467–472PubMedGoogle Scholar
  24. 24.
    Yegin O (1983) Chemotaxis in childhood. Pediatr Res 17: 183–187PubMedCrossRefGoogle Scholar
  25. 25.
    Raghunathan R, Miller ME, Everett S, Leake RD (1982) Phagocyte chemotaxis in the perinatal period. J Clin Immunol 2: 242–245PubMedCrossRefGoogle Scholar
  26. 26.
    Hawes CS, Kemp AS, Jones WR (1980) In vitro parameters of cellmediated immunity in the human neonate. Clin Immunol Immunopathol 17: 530–536PubMedCrossRefGoogle Scholar
  27. 27.
    Baehner RL (1975) Microbe ingestion and killing by neutrophils: Normal mechanisms and abnormalities. Clin Haematol 4: 609–633PubMedGoogle Scholar
  28. 28.
    Bainton DF (1981) Selective abnormalities of azurophil and specific granules of human neutrophilic leukocytes. Fed Proc 40: 1443–1450PubMedGoogle Scholar
  29. 29.
    Kjeldsen L, Sengelov H, Lollike K, Borregaard N (1996) Granules and secretory vesicles in human neonatal neutrophils. Pediatr Res 40: 120–129PubMedCrossRefGoogle Scholar
  30. 30.
    Ambruso DR, Bentwood B, Henson PM, Johnston RB Jr (1984) Oxidative metabolism of cord blood neutrophils: Relationship to content and degranulation of cytoplasmic granules. Pediatr Res 18: 1148–1153Google Scholar
  31. 31.
    McCracken GH Jr, Eichenwald HF (1971) Leukocyte function and the development of opsonic and complement activity in the neonate. Am J Dis Child 121: 120–126PubMedGoogle Scholar
  32. 32.
    Harris MC, Stroobant J, Cody CS et al (1983) Phagocytosis of group b streptococcus by neutrophils from newborn infants. Pediatr Res 17: 358–361PubMedCrossRefGoogle Scholar
  33. 33.
    Forman ML, Stiehm ER (1969) Impaired opsonic activity but normal phagocytosis in low-birth-weight infants. N Engl J Med 281: 926–931PubMedCrossRefGoogle Scholar
  34. 34.
    Xanthou M, Valassi-Adam E, Kintsonidou E, Matsaniotis N (1975) Phagocytosis and killing ability of candida albicans by blood leucocytes of healthy term and preterm babies. Arch Dis Child 50: 72–75PubMedCrossRefGoogle Scholar
  35. 35.
    Bektas S, Goetze B, Speer CP (1990) Decreased adherence, chemotaxis and phagocytic activities of neutrophils from preterm neonates. Acta Paediatr Scand 79: 1031–1038PubMedCrossRefGoogle Scholar
  36. 36.
    Al-Hadithy H, Addison IE, Goldstone AH et al (1981) Defective neutrophil function in low-birth-weight, premature infants. J Clin Pathol 34: 366–370PubMedCrossRefGoogle Scholar
  37. 37.
    Schuit KE, Powell DA (1980) Phagocytic dysfunction in monocytes of normal newborn infants. Pediatrics 65: 501–504PubMedGoogle Scholar
  38. 38.
    Speer CP, Johnston RBJ (1984) Phagocyte function. In: Ogra PL (ed) Neonatal infections: Nutritional and immunologic interactions. Grune & Stratton, Orlando, pp 21–36Google Scholar
  39. 39.
    Marodi L, Leijh PC, van Furth R (1984) Characteristics and functional capacities of human cord blood granulocytes and monocytes. Pediatr Res 18: 1127–1131PubMedCrossRefGoogle Scholar
  40. 40.
    Speer CP, Gahr M, Wieland M, Eber S (1988) Phagocytosis-associated functions in neonatal monocyte-derived macrophages. Pediatr Res 24: 213–216PubMedCrossRefGoogle Scholar
  41. 41.
    D’Ambola JB, Sherman MP, Tashkin DP, Gong H Jr (1988) Human and rabbit newborn lung macrophages have reduced anti-candida activity. Pediatr Res 24: 285–290PubMedCrossRefGoogle Scholar
  42. 42.
    Erdman SH, Christensen RD, Bradley PP, Rothstein G (1982) Supply and release of storage neutrophils. A developmental study. Biol Neonate 41: 132–137Google Scholar
  43. 43.
    Christensen RD, Rothstein G (1980) Exhaustion of mature marrow neutrophils in neonates with sepsis. J Pediatr 96: 316–318PubMedCrossRefGoogle Scholar
  44. 44.
    Christensen RD (1989) Neutrophil kinetics in the fetus and neonate. Am J Pediatr Hematol Oncol 11: 215–223PubMedGoogle Scholar
  45. 45.
    al-Mulla ZS, Christensen RD (1995) Neutropenia in the neonate. Clin Perinatol 22: 711–739PubMedGoogle Scholar
  46. 46.
    Rodwell RL, Taylor KM, Tudehope DI, Gray PH (1993) Hematologic scoring system in early diagnosis of sepsis in neutropenic newborns. Pediatr Infect Dis J 12: 372–376PubMedCrossRefGoogle Scholar
  47. 47.
    Carr R (2000) Neutrophil production and function in newborn infants. Br J Haematol 110: 18–28PubMedCrossRefGoogle Scholar
  48. 48.
    Hill HR (1987) Biochemical, structural, and functional abnormalities of polymorphonuclear leukocytes in the neonate. Pediatr Res 22: 375–382PubMedCrossRefGoogle Scholar
  49. 49.
    Koenig JM, Christensen RD (1989) Incidence, neutrophil kinetics, and natural history of neonatal neutropenia associated with maternal hypertension. N Engl J Med 321: 557–562PubMedCrossRefGoogle Scholar
  50. 50.
    Engle WD, Rosenfeld CR (1984) Neutropenia in high-risk neonates. J Pediatr 105: 982–986PubMedCrossRefGoogle Scholar
  51. 51.
    Doron MW, Makhlouf RA, Katz VL et al (1994) Increased incidence of sepsis at birth in neutropenic infants of mothers with preeclampsia. J Pediatr 125: 452–458PubMedCrossRefGoogle Scholar
  52. 52.
    Cadnapaphornchai M, Faix RG (1992) Increased nosocomial infection in neutropenic low birth weight (2000 grams or less) infants of hypertensive mothers. J Pediatr 121: 956–961PubMedCrossRefGoogle Scholar
  53. 53.
    Lux SE, Johnston RB Jr, August CS et al (1970) Chronic neutropenia and abnormal cellular immunity in cartilage-hair hypoplasia. N Engl J Med 282: 231–236PubMedCrossRefGoogle Scholar
  54. 54.
    Bertrand Y, Muller SM, Casanova JL et al (2002) Reticular dysgenesis: Hla non-identical bone marrow transplants in a series of 10 patients. Bone Marrow Transplant 29: 759–762PubMedCrossRefGoogle Scholar
  55. 55.
    Roper M, Parmley RT, Crist WM et al (1985) Severe congenital leukopenia (reticular dysgenesis). Immunologic and morphologic characterizations of leukocytes. Am J Dis Child 139: 832–835Google Scholar
  56. 56.
    De Santes KB, Lai SS, Cowan MJ (1996) Haploidentical bone marrow transplants for two patients with reticular dysgenesis. Bone Marrow Transplant 17: 1171–1173PubMedGoogle Scholar
  57. 57.
    Savage SA, Alter BP (2009) Dyskeratosis congenita. Hematol Oncol Clin North Am 23: 215–231PubMedCrossRefGoogle Scholar
  58. 58.
    Etzioni A (2010) Defects in the leukocyte adhesion cascade. Clin Rev Allergy Immunol 38: 54–60PubMedCrossRefGoogle Scholar
  59. 59.
    Phillips ML, Schwartz BR, Etzioni A et al (1995) Neutrophil adhesion in leukocyte adhesion deficiency syndrome type 2. J Clin Invest 96: 2898–2906PubMedCrossRefGoogle Scholar
  60. 60.
    Introne W, Boissy RE, Gahl WA (1999) Clinical, molecular, and cell biological aspects of chediak-higashi syndrome. Mol Genet Metab 68: 283–303PubMedCrossRefGoogle Scholar
  61. 61.
    Curnutte J, Orkin S, Dinaur M (1994) Genetic disorders of phagocyte function. In: Stamoyannopoulos G (ed) The molecular basis of blood diseases. WB Saunders, Philadelphia, pp 493–522Google Scholar
  62. 62.
    Roos D, de Boer M, Kuribayashi F et al (1996) Mutations in the x–linked and autosomal recessive forms of chronic granulomatous disease. Blood 87: 1663–1681PubMedGoogle Scholar
  63. 63.
    Gallin JI, Buescher ES, Seligmann BE et al (1983) NIH conference. Recent advances in chronic granulomatous disease. Ann Intern Med 99: 657–674Google Scholar
  64. 64.
    Finn A, Hadzic N, Morgan G et al (1990) Prognosis of chronic granulomatous disease. Arch Dis Child 65: 942–945PubMedCrossRefGoogle Scholar
  65. 65.
    Segal AW (1996) The nadph oxidase and chronic granulomatous disease. Mol Med Today 2: 129–135PubMedCrossRefGoogle Scholar
  66. 66.
    The international chronic granulomatous disease cooperative study group (1991) A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med 324: 509–516CrossRefGoogle Scholar
  67. 67.
    Weening RS, Kabel P, Pijman P, Roos D (1983) Continuous therapy with sulfamethoxazole-trimethoprim in patients with chronic granulomatous disease. J Pediatr 103: 127–130PubMedCrossRefGoogle Scholar
  68. 68.
    Calvino MC, Maldonado MS, Otheo E et al (1996) Bone marrow transplantation in chronic granulomatous disease. Eur J Pediatr 155: 877–879PubMedCrossRefGoogle Scholar
  69. 69.
    Ho CM, Vowels MR, Lockwood L, Ziegler JB (1996) Successful bone marrow transplantation in a child with x-linked chronic granulomatous disease. Bone Marrow Transplant 18: 213–215PubMedGoogle Scholar
  70. 70.
    Kamani N, August CS, Campbell DE et al (1988) Marrow transplantation in chronic granulomatous disease: An update, with 6- year follow-up. J Pediatr 113: 697–700PubMedCrossRefGoogle Scholar
  71. 71.
    Karlsson S (1991) Treatment of genetic defects in hematopoietic cell function by gene transfer. Blood 78: 2481–2492PubMedGoogle Scholar
  72. 72.
    Boxer LA, Greenberg MS, Boxer GJ, Stossel TP (1975) Autoimmune neutropenia. N Engl J Med 293: 748–753PubMedCrossRefGoogle Scholar
  73. 73.
    Lalezari P, Jiang AF, Yegen L, Santorineou M (1975) Chronic autoimmune neutropenia due to anti-na2 antibody. N Engl J Med 293: 744–747PubMedCrossRefGoogle Scholar
  74. 74.
    Lyall EG, Lucas GF, Eden OB (1992) Autoimmune neutropenia of infancy. J Clin Pathol 45: 431–434PubMedCrossRefGoogle Scholar
  75. 75.
    Bux J, Behrens G, Jaeger G, Welte K (1998) Diagnosis and clinical course of autoimmune neutropenia in infancy: Analysis of 240 cases. Blood 91: 181–186PubMedGoogle Scholar
  76. 76.
    Cartwright GE, Athens JW, Wintrobe MM (1964) The kinetics of granulopoiesis in normal man. Blood 24: 780–803PubMedGoogle Scholar
  77. 77.
    Koenig JM, Christensen RD (1989) Neutropenia and thrombocytopenia in infants with Rh hemolytic disease. J Pediatr 114 (4 Part 1): 625–631PubMedGoogle Scholar
  78. 78.
    Koenig JM, Christensen RD (1991) The mechanism responsible for diminished neutrophil production in neonates delivered of women with pregnancy-induced hypertension. Am J Obstet Gynecol 165: 467–473PubMedGoogle Scholar
  79. 79.
    Schelonka RL, Yoder BA, desJardins SE et al (1994) Peripheral leukocyte count and leukocyte indexes in healthy newborn term infants. J Pediatr 125: 603–606PubMedCrossRefGoogle Scholar
  80. 80.
    Mack DR, Forstner GG, Wilschanski M et al (1996) Shwachman syndrome: Exocrine pancreatic dysfunction and variable phenotypic expression. Gastroenterology 111: 1593–1602Google Scholar
  81. 81.
    Shwachman H, Diamond LK, Oski FA, Khaw KT (1964) The syndrome of pancreatic insufficiency and bone marrow dysfunction. J Pediatr 65: 645–663PubMedCrossRefGoogle Scholar
  82. 82.
    Smith OP, Hann IM, Chessells JM et al (1996) Haematological abnormalities in Shwachman-Diamond syndrome. Br J Haematol 94: 279–284PubMedCrossRefGoogle Scholar
  83. 83.
    Kostmann R (1956) Infantile genetic agranulocytosis; agranulocytosis infantilis hereditaria. Acta Paediatr Suppl 45 (Suppl 105): 1–78PubMedGoogle Scholar
  84. 84.
    Bonilla MA, Gillio AP, Ruggeiro M et al (1989) Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med 320: 1574–1580PubMedCrossRefGoogle Scholar
  85. 85.
    Homans AC, Verissimo AM, Vlacha V (1993) Transient abnormal myelopoiesis of infancy associated with trisomy 21. Am J Pediatr Hematol Oncol 15: 392–399PubMedGoogle Scholar
  86. 86.
    Bux J, Kober B, Kiefel V, Mueller-Eckhardt C (1993) Analysis of granulocyte-reactive antibodies using an immunoassay based upon monoclonal-antibody-specific immobilization of granulocyte antigens. Transfus Med 3: 157–162PubMedCrossRefGoogle Scholar
  87. 87.
    Bux J (2001) Molecular nature of granulocyte antigens. Transfus Clin Biol 8: 242–247PubMedCrossRefGoogle Scholar
  88. 88.
    Gorlin JB (1993) The phagocyte system: Structure and function. In: Nathan D (ed) Heamatology of infancy and childhood, Vol 2, 4 edn. WB Saunders, Philadelphia, p 882Google Scholar
  89. 89.
    Brodeur GM, Dahl GV, Williams DL et al (1980) Transient leukemoid reaction and trisomy 21 mosaicism in a phenotypically normal newborn. Blood 55: 691–693PubMedGoogle Scholar
  90. 90.
    Seibel NL, Sommer A, Miser J (1984) Transient neonatal leukemoid reactions in mosaic trisomy 21. J Pediatr 104: 251–254PubMedCrossRefGoogle Scholar
  91. 91.
    Freedman RM, Ingram DL, Gross I et al (1981) A half century of neonatal sepsis at yale: 1928 to 1978. Am J Dis Child 135: 140–144PubMedGoogle Scholar
  92. 92.
    Gladstone IM, Ehrenkranz RA, Edberg SC, Baltimore RS (1990) A ten-year review of neonatal sepsis and comparison with the previous fifty-year experience. Pediatr Infect Dis J 9: 819–825PubMedCrossRefGoogle Scholar
  93. 93.
    Miller ME (1977) Host defenses in the human neonate. Pediatr Clin North Am 24: 413–423PubMedGoogle Scholar
  94. 94.
    Siegel JD, McCracken GH Jr (1981) Sepsis neonatorum. N Engl J Med 304: 642–647PubMedCrossRefGoogle Scholar
  95. 95.
    Philip AG, Hewitt JR (1980) Early diagnosis of neonatal sepsis. Pediatrics 65: 1036–1041PubMedGoogle Scholar
  96. 96.
    Stoll BJ, Hansen N, Fanaroff AA et al (2002) Late-onset sepsis in very low birth weight neonates: The experience of the NICHD neonatal research network. Pediatrics 110 (2 Part 1): 285–291PubMedCrossRefGoogle Scholar
  97. 97.
    Rubin LG, Sanchez PJ, Siegel J et al (2002) Evaluation and treatment of neonates with suspected late–onset sepsis: A survey of neonatologists’ practices. Pediatrics 110: e42Google Scholar
  98. 98.
    WHO (1999) Bacterial etiology of serious infections in young infants in developing countries: Results of a multicenter study. The WHO young infants study group. Pediatr Infect Dis J 18 (Suppl 10): S17–S22Google Scholar
  99. 99.
    Isaacs D, Barfield C, Clothier T et al (1996) Late-onset infections of infants in neonatal units. J Paediatr Child Health 32: 158–161PubMedCrossRefGoogle Scholar
  100. 100.
    Craft AP, Finer NN, Barrington KJ (2000) Vancomycin for prophylaxis against sepsis in preterm neonates. Cochrane Database Syst Rev 2:CD001971Google Scholar
  101. 101.
    Blair E, Stanley FJ (1982) An epidemiological study of cerebral palsy in western australia, 1956–1975. Iii: Postnatal aetiology. Dev Med Child Neurol 24: 575–585Google Scholar
  102. 102.
    Waugh J, O’Callaghan MJ, Tudehope DI et al (1996) Prevalence and aetiology of neurological impairment in extremely low birthweight infants. J Paediatr Child Health 32: 120–124PubMedCrossRefGoogle Scholar
  103. 103.
    Stoll BJ, Hansen NI, Adams-Chapman I et al (2004) Neurodevelopmental and growth impairment among extremely low-birthweight infants with neonatal infection. JAMA 292: 2357–2365PubMedCrossRefGoogle Scholar
  104. 104.
    Bolande R (1995) The prenatal origins of cancer. In: Reed G, Claireaux A Cockburn F (eds) Diseases of the fetus and newborn: Pathology, imaging, genetics adn management. Chapman and Hall Medical, New York, p 67Google Scholar
  105. 105.
    American Society of Clinical Oncology (1994) Recommendations for the use of hematopoietic colony-stimulating factors: Evidencebased, clinical practice guidelines. J Clin Oncol 12: 2471–2508Google Scholar
  106. 106.
    Bernini JC, Wooley R, Buchanan GR (1996) Low-dose recombinant human granulocyte colony-stimulating factor therapy in children with symptomatic chronic idiopathic neutropenia. J Pediatr 129: 551–558PubMedCrossRefGoogle Scholar
  107. 107.
    Chanock SJ, Gorlin JB (1996) Granulocyte transfusions. Time for a second look. Infect Dis Clin North Am 10: 327–343Google Scholar
  108. 108.
    Sachs UJ, Reiter A, Walter T et al (2006) Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections. Transfusion 46: 1909–1914PubMedCrossRefGoogle Scholar
  109. 109.
    Grigull L, Pulver N, Goudeva L et al (2006) G-CSF mobilised granulocyte transfusions in 32 paediatric patients with neutropenic sepsis. Support Care Cancer 14: 910–916PubMedCrossRefGoogle Scholar
  110. 110.
    Grigull L, Beilken A, Schmid H et al (2006) Secondary prophylaxis of invasive fungal infections with combination antifungal therapy and G-CSF-mobilized granulocyte transfusions in three children with hematological malignancies. Support Care Cancer 14: 783–786PubMedCrossRefGoogle Scholar
  111. 111.
    Cesaro S, Chinello P, De Silvestro G et al (2003) Granulocyte transfusions from G-CSF-stimulated donors for the treatment of severe infections in neutropenic pediatric patients with onco-hematological diseases. Support Care Cancer 11: 101–106PubMedCrossRefGoogle Scholar
  112. 112.
    Engelfriet CP, Reesink HW, Klein HG et al (2000) International forum: Granulocyte transfusions. Vox Sang 79: 59–66Google Scholar
  113. 113.
    Mohan P, Brocklehurst P (2003) Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropaenia. Cochrane Database Syst Rev 4:CD003956Google Scholar
  114. 114.
    Christensen RD, Rothstein G, Anstall HB, Bybee B (1982) Granulocyte transfusions in neonates with bacterial infection, neutropenia, and depletion of mature marrow neutrophils. Pediatrics 70: 1–6PubMedGoogle Scholar
  115. 115.
    Baley JE, Stork EK, Warkentin PI, Shurin SB (1987) Buffy coat transfusions in neutropenic neonates with presumed sepsis: A prospective, randomized trial. Pediatrics 80: 712–720Google Scholar
  116. 116.
    Wheeler JG, Chauvenet AR, Johnson CA et al (1987) Buffy coat transfusions in neonates with sepsis and neutrophil storage pool depletion. Pediatrics 79: 422–425PubMedGoogle Scholar
  117. 117.
    Cairo MS, Worcester CC, Rucker RW et al (1992) Randomized trial of granulocyte transfusions versus intravenous immune globulin therapy for neonatal neutropenia and sepsis [see comments]. J Pediatr 120 (2 Part 1): 281–285PubMedGoogle Scholar
  118. 118.
    Ohlsson A, Lacy JB (2004) Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants. Cochrane Database Syst Rev 1:CD000361Google Scholar
  119. 119.
    Haque KN, Zaidi MH, Haque SK et al (1986) Intravenous immunoglobulin for prevention of sepsis in preterm and low birth weight infants. Pediatr Infect Dis 5: 622–625PubMedCrossRefGoogle Scholar
  120. 120.
    Bussel JB (1990) Intravenous gammaglobulin in the prophylaxis of late sepsis in very-low-birth-weight infants: Preliminary results of a randomized, double-blind, placebo-controlled trial. Rev Infect Dis 12 (Suppl 4): S457–S461PubMedCrossRefGoogle Scholar
  121. 121.
    Atici A, Satar M, Karabay A, Yilmaz M (1996) Intravenous immunoglobulin for prophylaxis of nosocomial sepsis. Indian J Pediatr 63: 517–521PubMedCrossRefGoogle Scholar
  122. 122.
    Christensen RD, Hardman T, Thornton J, Hill HR (1989) A randomized, double-blind, placebo-controlled investigation of the safety of intravenous immune globulin administration to preterm neonates. J Perinatol 9: 126–130PubMedGoogle Scholar
  123. 123.
    Ratrisawadi V, Srisuwanporn T, Puapondh Y (1991) Intravenous immunoglobulin prophylaxis for infection in very low birth-weight infants. J Med Assoc Thai 74: 14–18PubMedGoogle Scholar
  124. 124.
    Weisman LE, Stoll BJ, Kueser TJ et al (1994) Intravenous immune globulin prophylaxis of late-onset sepsis in premature neonates. J Pediatr 125 (6 Part 1): 922–930PubMedGoogle Scholar
  125. 125.
    Stabile A, Miceli Sopo S, Romanelli V et al (1988) Intravenous immunoglobulin for prophylaxis of neonatal sepsis in premature infants. Arch Dis Child 63: 441–443PubMedCrossRefGoogle Scholar
  126. 126.
    Shah PS, Kaufman DA (2009) Antistaphylococcal immunoglobulins to prevent staphylococcal infection in very low birth weight infants. Cochrane Database Syst Rev 2:CD006449Google Scholar
  127. 127.
    Bloom B, Schelonka R, Kueser T et al (2005) Multicenter study to assess safety and efficacy of inh-a21, a donor-selected human staphylococcal immunoglobulin, for prevention of nosocomial infections in very low birth weight infants. Pediatr Infect Dis J 24: 858–866PubMedCrossRefGoogle Scholar
  128. 128.
    DeJonge M, Burchfield D, Bloom B et al (2007) Clinical trial of safety and efficacy of inh-a21 for the prevention of nosocomial staphylococcal bloodstream infection in premature infants. J Pediatr 151: 260–265CrossRefGoogle Scholar
  129. 129.
    Benjamin DK, Schelonka R, White R et al (2006) A blinded, randomized, multicenter study of an intravenous staphylococcus aureus immune globulin. J Perinatol 26: 290–295PubMedCrossRefGoogle Scholar
  130. 130.
    Ohlsson A, Lacy JB (2004) Intravenous immunoglobulin for suspected or subsequently proven infection in neonates. Cochrane Database Syst Rev 1:CD001239Google Scholar
  131. 131.
    Chen JY (1996) Intravenous immunoglobulin in the treatment of full-term and premature newborns with sepsis. J Formos Med Assoc 95: 839–844PubMedGoogle Scholar
  132. 132.
    Christensen RD, Brown MS, Hall DC et al (1991) Effect on neutrophil kinetics and serum opsonic capacity of intravenous administration of immune globulin to neonates with clinical signs of early-onset sepsis. J Pediatr 118 (4 Part 1): 606–614PubMedGoogle Scholar
  133. 133.
    Erdem G, Yurdakok M, Tekinalp G, Ersoy F (1993) The use of IgM-enriched intravenous immunoglobulin for the treatment of neonatal sepsis in preterm infants. Turk J Pediatr 35: 277–281PubMedGoogle Scholar
  134. 134.
    Haque KN, Zaidi MH, Bahakim H (1988) IgM-enriched intravenous immunoglobulin therapy in neonatal sepsis. Am J Dis Child 142: 1293–1296PubMedGoogle Scholar
  135. 135.
    Mancilla-Ramirez J, Gonzalez-Yunes R, Castellanos-Cruz C et al (1992) [intravenous immunoglobulin in the treatment of neonatal septicemia]. Bol Med Hosp Infant Mex 49: 4–11Google Scholar
  136. 136.
    Shenoi A, Nagesh NK, Maiya PP et al (1999) Multicenter randomized placebo controlled trial of therapy with intravenous immunoglobulin in decreasing mortality due to neonatal sepsis. Indian Pediatr 36: 1113–1118PubMedGoogle Scholar
  137. 137.
    Sidiropoulos D, Boehme U, Von Muralt G et al (1986) Immunoglobulin supplementation in prevention or treatment of neonatal sepsis. Pediatr Infect Dis 5 (Suppl 3): S193–S194PubMedCrossRefGoogle Scholar
  138. 138.
    Weisman LE, Stoll BJ, Kueser TJ et al (1992) Intravenous immune globulin therapy for early-onset sepsis in premature neonates [see comments]. J Pediatr 121: 434–443PubMedCrossRefGoogle Scholar
  139. 139.
    Dallorso S, Manzitti C, Dodero P et al (2003) Uneventful outcome of unrelated hematopoietic stem cell transplantation in a patient with leukemic transformation of kostmann syndrome and long-lasting invasive pulmonary mycosis. Eur J Haematol 70: 322–325PubMedCrossRefGoogle Scholar
  140. 140.
    Toyoda H, Azuma E, Hori H et al (2001) Successful unrelated bmt in a patient with kostmann syndrome complicated by pre-transplant pulmonary ‘bacterial’ abscesses. Bone Marrow Transplant 28: 413–415PubMedCrossRefGoogle Scholar
  141. 141.
    Freedman MH, Alter BP (2002) Risk of myelodysplastic syndrome and acute myeloid leukemia in congenital neutropenias. Semin Hematol 39: 128–133PubMedCrossRefGoogle Scholar
  142. 142.
    Elhasid R, Rowe JM (2010) Hematopoetic stem cell transplantation in neutrophil disorders: Severe congenital neutropenia, leukocyte adhesion deficiency and chronic granulomatous disease. Clin Rev Allergy Immunol 38: 61–67Google Scholar
  143. 143.
    van den Berg JM, van Koppen E, Ahlin A et al (2009) Chronic granulomatous disease: The european experience. PLoS One 4: e5234Google Scholar
  144. 144.
    Kang EM, Malech HL (2009) Advances in treatment for chronic granulomatous disease. Immunol Res 43: 77–84PubMedCrossRefGoogle Scholar
  145. 145.
    Moreno-Carranza B, Gentsch M, Stein S et al (2009) Transgene optimization significantly improves sin vector titers, gp91phox expression and reconstitution of superoxide production in x-cgd cells. Gene Ther 16: 111–118PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2012

Authors and Affiliations

  • Kurt R. Schibler
    • 1
  1. 1.Department of Pediatrics, Division of NeonatologyCincinnati Children’s Hospital Medical CenterCincinnatiUSA

Personalised recommendations